Equities

Altamira Therapeutics Ltd

CYTO:NAQ

Altamira Therapeutics Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.499
  • Today's Change-0.006 / -1.19%
  • Shares traded24.16k
  • 1 Year change-78.60%
  • Beta2.4613
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in CHF

The one analyst offering a 12 month price target expects Altamira Therapeutics Ltd share price to rise to 5.30 in the next year from the last price of 0.499.
High962.0%5.30
Med962.0%5.30
Low962.0%5.30

Earnings history & estimates in CHF

On Nov 15, 2018, losses of -2.80 per share.
Average growth rate-622.72%
Altamira Therapeutics Ltd reported annual 2023 losses of -7.88 per share on Apr 10, 2024.
Average growth rate-10,412.17%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.